A Peek Into The Market Before The Trading Starts

Pre-open movers US stock futures are higher this morning, as investors are awaiting pending home sales report. Futures for the Dow Jones Industrial Average gained 47 points to 13,079.00 and S&P 500 index futures rose 4.90 points to 1,399.00. Nasdaq 100 futures gained 13.75 points to 2,742.50. A Peek Into Global Markets European markets were mostly higher today. The STOXX Europe 600 Index gained 0.55%, London's FTSE 100 Index moved up 0.48%, French CAC 40 index rose 0.11% and German DAX 30 index gained 0.63%. Asian markets ended mixed, with Japan's Nikkei Stock Average rising 0.07%, China's Shanghai Composite gaining 0.05% and Australia's S&P/ASX 200 moving down 0.13%. India's Sensex dipped 1.78%. Broker Recommendation Analysts at Credit Suisse downgraded Safeway Inc SWY from “outperform” to “neutral.” The target price for Safeway has been lowered from $26 to $20. Safeway shares gained 1.29% to close at $21.13 on Friday. Breaking news

• Raptor Pharmaceutical Corp RPTP, announced that the European Medicines Agency has determined that Raptor's Marketing Authorization Application (MAA) for its investigational drug candidate, RP103 for the potential treatment of nephropathic cystinosis, submitted earlier this month, is valid. To read the full news, click here.
• Camtek Ltd CAMT announced today that a leading global OSAT (Outsourced Semiconductor Assembly and Test house) selected the Company's Falcon family of inspection products for various applications within the backend semiconductor process. To read the full news, click here.
• VIVUS Inc VVUS today announced that a Marketing Authorization Application has been accepted by the European Medicines Agency for the review of avanafil, its investigational drug for the treatment of erectile dysfunction.To read the full news, click here.
• AstraZeneca Plc AZN today announced that on March 23, 2012 the US District Court for the District of Columbia issued an opinion and order in AstraZeneca's lawsuit against the US Food and Drug Administration (FDA) regarding final marketing approval of generic quetiapine. To read the full news, click here.